Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06733480 · ClinicalTrials.gov registry record · NA
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
A NA study of Rotator Cuff Tears and Reverse Total Shoulder Arthroplasty, sponsored by University Hospitals Cleveland Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 499
- Enrollment target
- 1
- Study location
NCT06733480: Recruiting NA study of Rotator Cuff Tears and Reverse Total Shoulder Arthroplasty, sponsored by University Hospitals Cleveland Medical Center.
NCT06733480 is a NA study of Rotator Cuff Tears and Reverse Total Shoulder Arthroplasty that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 499 participants, below the 1,256-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06733480, a NA study of Rotator Cuff Tears and Reverse Total Shoulder Arthroplasty, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 499 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants are being invited to take part in this research study because you will be undergoing total shoulder replacement or rotator cuff repair and will be participating in physical therapy rehabilitation following the procedure. The purpose of this research is to investigate the effectiveness of Band Connect, a connected health platform, in enhancing compliance with home exercise programs among patients undergoing physical therapy. This study aims to evaluate the implications of increased compliance on improving patient engagement and increasing satisfaction for both patients and clinicians. Additionally, the study will analyze the economic implications of implementing Band Connect's hybrid care model on driving increased revenue per patient.
Conditions Studied
Interventions
- DEVICE Band Connect
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2025-02-04 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT06733480 shows while recruiting
NCT06733480 is an interventional study that assigns participants to a tested intervention. The registered 499 participants enrollment target is mid-sized for trials with a published cap, below the 1,256-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (60% lower).
The record links to 3 conditions, with Rotator Cuff Tears appearing as the primary indexed condition, and to 1 intervention - of which Band Connect is the first listed.
NCT06733480 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06733480 about?
NCT06733480 is a clinical study titled "Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue". Participants are being invited to take part in this research study because you will be undergoing total shoulder replacement or rotator cuff repair and will be participating in physical therapy rehabilitation following the procedure. The purpose of this research is to investigate the effectiveness o...
What is the current status of trial NCT06733480?
This trial is currently recruiting. It is a NA study. The enrollment target is 499 participants. The study started on 2025-02-04. Estimated completion is 2026-06-01.
What conditions does trial NCT06733480 study?
This clinical trial studies the following conditions: Rotator Cuff Tears, Reverse Total Shoulder Arthroplasty, Anatomic Total Shoulder Arthroplasty.
What interventions are being tested in trial NCT06733480?
The interventions under investigation include: Band Connect (DEVICE).
Who is sponsoring clinical trial NCT06733480?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06733480 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tears
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06733480's enrollment target sits among peer trials
499 3rd of 20 higher than 18 of 20 other Rotator Cuff Tears trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rotator Cuff Tears trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
FiberLocker® System Augmentation of Rotator Cuff Repairs
RECRUITING · NA
-
InSpace Accelerated Rehabilitation Study
RECRUITING · NA
-
Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair
RECRUITING · NA
-
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
RECRUITING · NA
-
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
RECRUITING · NA
-
RSA Vs RCR for Massive RCTs
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04137900 · 499 participants · Phase 1
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI